| 1. | To develop guidelines for PMCs |
| 2. | To provide evidence that patient education and counseling in PMCs are valuable in the following viewpoints: |
| a. adherence to pharmacotherapy | |
| b. knowledge about pharmacotherapy | |
| c. clinical outcome | |
| d. cost-effectiveness | |
| 3. | Outreach activity for PMCs |